# A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation

> **NCT00667888** · PHASE3 · UNKNOWN · sponsor: **M.D. Anderson Cancer Center** · enrollment: 225 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Conventional Fractionated Intensity Modulated Radiotherapy
- **RADIATION:** Hypofractionated Intensity Modulated Radiotherapy

## Key facts

- **NCT ID:** NCT00667888
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-01-03
- **Primary completion:** 2015-10-12
- **Final completion:** 2021-10
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2021-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00667888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00667888, "A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00667888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*